Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
9.88
-0.46 (-4.45%)
Apr 15, 2026, 4:00 PM EDT - Market closed
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $537.67 million as of April 16, 2026. Its market cap has increased by 45.90% in one year.
Market Cap
537.67M
Enterprise Value
197.43M
1-Year Change
45.90%
Ranking
Category
Stock Price
$9.88
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $537.67M, an increase of 36.69%. That is a compound annual growth rate of 23.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 562.70M | -61.65% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 578.65M |
| Lyell Immunopharma | 578.54M |
| Kyverna Therapeutics | 573.72M |
| Zevra Therapeutics | 570.68M |
| Tectonic Therapeutic | 562.55M |
| Prothena Corporation | 555.02M |
| Rigel Pharmaceuticals | 553.64M |
| Aclaris Therapeutics | 542.08M |